Supplementary Appendix - Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

Name: Supplementary Appendix - Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
Creator: Abby Van Voorhees
Published: 2020-01-29T22:38:51.534Z
Keywords: Dermatology, Clinical Trial, Scalp, Psoriasis, Quality of Life, Pruritus

Van Voorhees, Abby; Stein Gold, Linda; Lebwohl, Mark; Strober, Bruce; Lynde, Charles; Tyring, Stephen; Cauthen, Ashley; Sofen, Howard; Zhang, Zuoshun; Paris, Maria; Wang, Yao

doi:10.17632/8gywzhsxcp.1

Supplementary Appendix - Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

Published: 29 January 2020| Version 1 | DOI: 10.17632/8gywzhsxcp.1

Contributors:

Abby Van Voorhees, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Charles Lynde, Stephen Tyring, Ashley Cauthen, Howard Sofen, Zuoshun Zhang, Maria Paris, Yao Wang

Description

Supplementary Appendix - Van Voorhees A, et. al. Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study. JAAD 2020

Supplementary Appendix - Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study

Description

Files

Categories

Licence